Quick Look Market Closing Price:
At the close: Dow +0.16% to 12929. S&P +0.42% to 1372. Nasdaq +0.54% to 2986.
Treasurys: 30-year -0.14%. 10-yr -0.11%. 5-yr -0.07%.
Commodities: Crude +0.88% to $107.52. Gold +0.93% to $1714.45.
Currencies: Euro -1.21% vs. dollar. Yen +1.09%. Pound +0.96%.
After Hours News:
Peregrine Pharmaceuticals (PPHM): FQ3 EPS of -$0.13 in-line. Revenue of $3.28M (+13.8% Y/Y) beats by $1.1M
Middleby (MIDD): Q4 EPS of $1.87 may not be comparable to consensus of $1.29. Revenue of $243.7M (+17.7% Y/Y) beats by $7M.
Anthera Pharmaceuticals (ANTH) halts its VISTA-16 clinical study due to a lack of efficacy that could not be reasonably overcome in the remainder of the trial, following a recommendation by the Independent Data Safety Monitoring Board. ANTH -63.4% AH.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/